CLINICAL_TRIALS ClinicalTrials.gov record update

Post-Authorisation Safety Study of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in a Real-World Setting

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02699879
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:35.975797+00:00
Published At: 2017-04-21T00:00:00+00:00
Record Updated At: 2017-04-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Idiopathic Pulmonary Fibrosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-04-21"
protocolSection.identificationModule.nctId: "NCT02699879"
protocolSection.identificationModule.officialTitle: "Post-Authorisation Safety Study of Esbriet\u00ae (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in a Real-World Setting"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.